The synthesis of a selective PDE4/TNFα inhibitor

被引:34
|
作者
Caron, S [1 ]
Vazquez, E [1 ]
机构
[1] Pfizer Global Res & Dev, Chem Res & Dev, Groton, CT 06340 USA
关键词
D O I
10.1021/op010223p
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Two syntheses of cis-4-cyano-4-(1-cyclohexyl-3-ethyl-1H-indazol-6-yl)cyclohexanecarboxylic acid (1), a selective PDE4/TNF alpha inhibitor are described. The first synthesis relied on a solvolysis of a tertiary benzylic alcohol to the nitrile using TMSCN and on the epimerization of an ester to its thermodynamically favored position prior to its hydrolysis. It was demonstrated that the selectivity was controlled by the rate of hydrolysis of the two diastereomeric esters. The second synthesis proved to be more efficient and used a novel nucleophilic aromatic substitution of a fluoroindazole with the anion of a tertiary nitrile. Another key element of the route was a selective Pinner reaction of a secondary nitrile in the presence of a tertiary nitrile.
引用
收藏
页码:587 / 592
页数:6
相关论文
共 50 条
  • [31] ORGN 699-Practical synthesis of the PDE4 inhibitor, KW-4490
    Yanagisawa, Arata
    Nishimura, Koichiro
    Nezu, Tetsuya
    Ando, Kyoji
    Maki, Ayako
    Imai, Eiichiro
    Mohri, Shin-ichiro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [32] Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice
    Alam, Imranul
    Hardman, Sara L.
    Gerard-O'Riley, Rita L.
    Acton, Dena
    Parker, Reginald S.
    Hong, Jung Min
    Bruzzaniti, Angela
    Econs, Michael J.
    CALCIFIED TISSUE INTERNATIONAL, 2024, 114 (04) : 419 - 429
  • [33] Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice
    Imranul Alam
    Sara L. Hardman
    Rita L. Gerard-O’Riley
    Dena Acton
    Reginald S. Parker
    Jung Min Hong
    Angela Bruzzaniti
    Michael J. Econs
    Calcified Tissue International, 2024, 114 : 419 - 429
  • [34] A practical synthesis of the PDE4 inhibitor, SB-207499, from a cyclohexanone precursor
    Badham, NF
    Chen, JH
    Cummings, PG
    Dell'Orco, PC
    Diederich, AM
    Eldridge, AM
    Mendelson, WL
    Mills, RJ
    Novack, VJ
    Olsen, MA
    Rustum, AM
    Webb, KS
    Yang, S
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2003, 7 (01) : 101 - 108
  • [35] NONSELECTIVE, BUT NOT SUBTYPE-SELECTIVE PDE4 INHIBITORS INDUCE EXPRESSION OF THE PRO-INFLAMMATORY PDE4 VARIANT PDE4B2
    Rodriguez, T.
    Lin, S.
    Blanchard, E.
    Saleh, L. A.
    Baskar, G.
    Boyd, A.
    Zlock, L.
    Finkbeiner, W.
    Richter, W.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 193 - 194
  • [36] Pharmacological activity of difamilast, a novel PDE4 inhibitor for the topical treatment of atopic dermatitis: Comparison with other PDE4 inhibitors
    Hiyama, Hidetaka
    Arichika, Naoya
    Sakurai, Kazushi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB255 - AB255
  • [37] PDE4 inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (12) : 571 - 571
  • [38] Antipsychotic potential of RO 20 1724, a PDE4 inhibitor
    Halene, T. B.
    Siegel, S. J.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S12 - S12
  • [39] Process Development of the PDE4 Inhibitor K-34
    Yanagisawa, Arata
    Taga, Masashi
    Atsumi, Toshiyuki
    Nishimura, Koichiro
    Ando, Kyoji
    Taguchi, Tsuyoshi
    Tsumuki, Hiroshi
    Chujo, Iwao
    Mohri, Shin-ichiro
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (02) : 376 - 381
  • [40] In vivo characterization of the PDE4 inhibitor MEM1414
    De Vivo, M
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 107S - 107S